Applied Clinical Trials podcast

ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval

0:00
1:30
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
In today’s ACT Brief, we examine how ZIP code shapes trial availability and enrollment, why smaller biotechs hold outdated views of APAC sites, and how FDA approved Pimjetmi for symptomatic tenosynovial giant cell tumor.

Fler avsnitt från "Applied Clinical Trials"